Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effect of Laughter Therapy on the Quality of Life and Psychological Well-being of Nursing Students

5 de noviembre de 2026 actualizado por: Fahriye Şeyma Kara, Çankırı Karatekin University

The nursing profession is a healthcare discipline that combines theoretical knowledge with clinical practice skills. The primary aim of nursing education is to train healthcare professionals who are prepared for the profession, aware of their duties and responsibilities, and capable of providing effective care to individuals and the community. During their education, nursing students face various challenges both in the academic sphere and in clinical settings. Students are confronted with numerous stressors, such as a heavy course load, preparing for examinations, undertaking clinical placements, a lack of self-confidence, and the changes brought about by the university environment. When this process is not managed effectively, it is thought that students' quality of life and psychological well-being may be adversely affected. Accordingly, there is a need for complementary health approaches to enhance nursing students' quality of life and to safeguard and promote their psychological well-being. Included among these complementary health approaches, laughter therapy has physiological and psychological effects on individuals. There are numerous positive effects associated with laughter, such as improving cognitive functions, enhancing respiration, increasing pain tolerance, improving sleep quality, reducing exam anxiety and lowering stress hormone levels.

Accordingly, the aim of this thesis is to investigate the effect of laughter therapy administered to nursing students on their quality of life and psychological well-being. A review of the literature revealed no existing studies on this topic. Consequently, it is anticipated that this planned thesis will make a significant contribution to filling this gap in the literature.

The study is planned as a randomised controlled experimental study using a pre-test-post-test-follow-up design. The research will be conducted with second-year nursing students at the Faculty of Health Sciences, Çankırı Karatekin University. A total of 112 students who meet the inclusion criteria and are allocated to the experimental (n=56) and control (n=56) groups via randomisation will form the study sample. Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. Session times will be planned together with the students in the experimental group who will receive laughter therapy. Research data will be collected using the Demographic Information Form, the SF-12 Quality of Life Scale and the Psychological Well-being Scale. IBM SPSS Statistics for Windows, Version 24.0, will be used to analyse the data obtained from this study.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

56

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Çankırı
      • Çankırı, Çankırı, Turquía (Türkiye)
        • Cankiri Kaatekin University
        • Contacto:
        • Investigador principal:
          • fahriye s kara

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Be a second-year nursing student in the Department of Nursing at Çankırı Karatekin University
  • Be able to speak and understand Turkish
  • Have no diagnosed psychiatric disorders
  • Have no communication difficulties
  • Agree to participate in laughter therapy sessions
  • Have no history of using psychotropic medications, either currently or in the past

Exclusion Criteria:

  • Failure to attend all laughter therapy sessions
  • Having a physical condition that would prevent participation in laughter therapy sessions
  • Having previously participated in laughter therapy
  • Using medication or another nonpharmacological method to reduce stress
  • Having difficulty performing breathing exercises
  • Not volunteering to participate in the study

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Grupo de Control Sin Intervención
Experimental: Laughter Therapy Group

Experimental group students will undergo a laughter therapy programme comprising a total of eight sessions, at a rate of two sessions per week; the control group will receive no intervention during the study period. The days and times for the laughter therapy sessions to be conducted with the experimental group will be planned in consultation with the students. The sessions will be held in a suitable classroom or conference room with the participants seated in a U-shaped arrangement. During the first session, students will receive a brief introduction and information about the activities to be conducted throughout the session. Each session aims to encourage spontaneous laughter by incorporating breathing exercises, rhythmic clapping and vocal exercises, playful and energetic games, "icebreaker laughter," and guided meditation. Each session is scheduled to last approximately 40 minutes.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in quality of life measured by the 12-item Quality of Life Scale
Periodo de tiempo: Baseline (before the intervention) and immediately after completion of the intervention

The scale was developed by Ware et al. in 1995. A validity and reliability study conducted by Soylu and Kütük in 2002 demonstrated that it is a measurement tool with adequate psychometric properties for assessing general health status and health-related quality of life in clinical practice and scientific research. The scale comprises 12 items across eight sub-dimensions: physical functioning (2 items), physical role (2 items), bodily pain (1 item), general health (1 item), energy (1 item), social functioning (1 item), emotional role (2 items) and mental health (2 items). Items relating to physical and emotional roles are answered on a dichotomous basis (yes or no), whilst the other items are measured on a Likert scale ranging from 3 to 6. A score of 100 on the scale indicates the best state of health, whilst a score of 0 indicates the worst state of health. In the Turkish validity and reliability study, the Cronbach's alpha coefficient was determined to be between 0.92 and 0.88.

Baseline (before the intervention) and immediately after completion of the intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in psychological well-being measued by the 8-item Psychological Well-being Scale
Periodo de tiempo: Baseline (before the intervention) and immediately after completion of the intervention

The scale identifies key elements of human functioning, ranging from positive relationships to feelings of competence and leading a meaningful and purposeful life. It was developed by Diener and colleagues in 2009. The adaptation into Turkish was carried out by Telef in 2011. In the reliability study of the scale, the Cronbach's alpha internal consistency coefficient was calculated as .80 The items on the Psychological Well-being Scale are rated on a scale of 1 to 7, ranging from 'I strongly disagree' (1) to 'I strongly agree' (7). All items are phrased in positive terms. Scores range from 8 to 56. A high score indicates that the individual possesses a wide range of psychological resources and strengths. Although the scale does not provide separate measurements of the various dimensions of well-being, it offers a general overview of positive functioning across different areas that we believe to be important.

Baseline (before the intervention) and immediately after completion of the intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: fahriye s kara, Çankırı Karatekin University
  • Director de estudio: mevlut karatas, professor, Çankırı Karatekin University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

1 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

28 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Publicado por primera vez (Actual)

9 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • ÇAKÜ-SB-2026-0051

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .